(Q35560154)

8 August 2017

1 reference

title

Improving evidence developed from population-level experience with targeted agents (English)

1 reference

8 August 2017

M B McClellan

1

1 reference

8 August 2017

G W Daniel

2

1 reference

8 August 2017

D Dickson

3

1 reference

8 August 2017

J Perlmutter

4

1 reference

8 August 2017

D P Berger

5

1 reference

8 August 2017

V Miller

6

1 reference

8 August 2017

S Nussbaum

7

1 reference

8 August 2017

J Malin

8

1 reference

8 August 2017

M H Romine

9

1 reference

8 August 2017

R L Schilsky

10

1 reference

8 August 2017

language of work or name

English

0 references

publication date

3 April 2015

1 reference

Clinical Pharmacology & Therapeutics

8 August 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 August 2017

97

1 reference

8 August 2017

478-487

1 reference

8 August 2017

5

1 reference

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

8 August 2017

1 reference

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

21 January 2018

1 reference

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients

21 January 2018

1 reference

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

21 January 2018

1 reference

Developing the Sentinel System--a national resource for evidence development

21 January 2018

1 reference

Launching PCORnet, a national patient-centered clinical research network

21 January 2018

1 reference

Patient-powered research networks aim to improve patient care and health research

21 January 2018

1 reference

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

21 January 2018

1 reference

Implementing personalized cancer care

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Admissible two-stage designs for phase II cancer clinical trials

21 January 2018

1 reference

Optimal two-stage designs for phase II clinical trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CPT.90

1 reference

8 August 2017

1 reference